A Prospective Observational Study on Targeted Therapy for Unresectable or Metastatic BRAFV600E Mutant Melanoma Patients
- Status
- COMPLETED
- Phase
- N/A
Clinical Trials Related to Metastatic Melanoma
Related studies linked through entity extraction aliases.
Nilotinib Plus Dabrafenib/Trametinib or Encorafenib/Binimetinib in Metastatic Melanoma
- Status
- RECRUITING
- Phase
- PHASE1
Troriluzole or Placebo Plus Ipi Plus Nivo in Mel Brain Mets
- Status
- TERMINATED
- Phase
- PHASE2
Precision Radiation of Immune Checkpoint Therapy Resistant Melanoma Metastases
- Status
- RECRUITING
- Phase
- NA
Bintrafusp Alfa and Pimasertib for the Treatment of Patients With Brain Metastases
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
Avapritinib for the Treatment of CKIT or PDGFRA Mutation-Positive Locally Advanced or Metastatic Malignant Solid Tumors
- Status
- RECRUITING
- Phase
- PHASE2
Hepatic Impairment Study of Encorafenib in Combination With Binimetinib in BRAF Melanoma
- Status
- WITHDRAWN
- Phase
- PHASE1
18F-FMAU PET/CT and MRI for the Detection of Brain Tumors in Patients With Brain Cancer or Brain Metastases
- Status
- COMPLETED
- Phase
- EARLY_PHASE1
Sargramostim (GM-CSF) + PD-1
- Status
- WITHDRAWN
- Phase
- PHASE2
CMP-001 in Combination With Nivolumab in Subjects With Advanced Melanoma
- Status
- TERMINATED
- Phase
- PHASE2
Establishment of the Human Intestinal and Salivary Microbiota Biobank - Oncologic Diseases
- Status
- COMPLETED
- Phase
- N/A
Intralesional Influenza Vaccine for the Treatment of Stage I-IV Melanoma
- Status
- RECRUITING
- Phase
- PHASE1
CMP-001 in Combination With Nivolumab Compared to Nivolumab Monotherapy in Subjects With Advanced Melanoma
- Status
- TERMINATED
- Phase
- PHASE2/PHASE3
Cryoablation Combined With Stereotactic Body Radiation Therapy for the Treatment of Painful Bone Metastases, the CROME Trial
- Status
- RECRUITING
- Phase
- NA
Diet and Immune Effects Trial: DIET- A Randomized Double Blinded Dietary Intervention Study in Patients With Metastatic Melanoma Receiving Immunotherapy
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Phase II Study of Olaparib and Pembrolizumab in Advanced Melanoma With Homologous Recombination (HR) Mutation
- Status
- UNKNOWN
- Phase
- PHASE2
A Clinical Study of the Safety and Activity of the Investigational Cell Therapy NEO-PTC-01 in Patients With Advanced Melanoma
- Status
- TERMINATED
- Phase
- PHASE1
In Situ Immunomodulation With CDX-301, Radiation Therapy, CDX-1140 and Poly-ICLC in Patients w/ Unresectable and Metastatic Solid Tumors
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1
Comparing Whole Brain Radiotherapy Using a Technique That Avoids the Hippocampus to Stereotactic Radiosurgery in Patients With Cancer That Has Spread to the Brain and Come Back in Other Areas of the Brain After Earlier Stereotactic Radiosurgery
- Status
- TERMINATED
- Phase
- PHASE3
Testing the Addition of the Anti-cancer Drug, Tazemetostat, to the Usual Treatment (Dabrafenib and Trametinib) for Metastatic Melanoma That Has Progressed on the Usual Treatment
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1/PHASE2